Screener
Amneal Pharmaceuticals, Inc. AMRX Specialty — Restructuring and other charges
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Three Months Ended June 30, 2026 | Affordable Medicines (1) | Specialty | Av KARE | Corporateand Other | Total Company |
|---|---|---|---|---|---|
| Selling, general and administrative | 42,367 | 40,095 | 16,913 | 49,347 | 148,722 |
| Research and development | 33,023 | 5,994 | — | — | 39,017 |
| Intellectual property legal development expenses | 2,002 | 85 | — | — | 2,087 |
| Acquisition costs | — | — | — | 7,600 | 7,600 |
| Restructuring and other charges | — | — | — | 554 | 554 |
| Charges related to legal matters, net | 8,057 | — | — | — | 8,057 |
| Other operating income | (1,298) | — | — | — | (1,298) |
| Operating income (loss) | $123,078 | $54,856 | $9,336 | $(57,501) | $129,769 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s specialty — restructuring and other charges?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — restructuring and other charges of $0 in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — restructuring and other charges changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — restructuring and other charges decreased by 100.0% year-over-year, from $341K to $0.
- What does specialty — restructuring and other charges mean?
- Costs associated with organizational realignments, facility consolidations, or workforce reductions within the specialty segment intended to improve long-term operational efficiency. These charges are typically excluded from core operating performance to highlight underlying business trends.
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — restructuring and other charges.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude